BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Liabilities
Everything the company owes to creditors and other parties.
BillionToOne, Inc.NASDAQ: BLLN
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities rises 34.4% from a year ago
Total liabilities stood at $192.89M at the end of Q2 FY2026, up 34.4% from a year earlier and down 1.1% from the prior quarter.
Context
- Total liabilities amounted to 26.4% of total assets at the end of Q2 FY2026, down 19.5 pp from a year earlier.
- Total liabilities increased in 1 of the last 2 fiscal years.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +34.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 152.55M USD
- Year-over-year change
- +13.6%
- 2-year CAGR
- -2.7%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 152.55M | +13.6% |
| FY2024 | 2024-12-31 | 134.31M | -16.7% |
| FY2023 | 2023-12-31 | 161.2M | — |
Total Liabilities vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total liabilities of $192.89M is the 7th highest of the 9 companies compared; the peer median is $318.67M.
- Its year-over-year change of +34.4% is the 3rd highest of 9, against a peer median of +19.4%.
- Total liabilities amounts to 26.4% of total assets for BLLN, versus a peer median of 36.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.16B | +32.5% | +10.9% | 114.6% | |
| Jun 2026 | $836M | +63.6% | +4.9% | 31.5% | |
| Jun 2026 | $565.65M | +4.8% | -11.0% | 41.8% | |
| Mar 2026 | $336.3M | +11.7% | +2.7% | 49.9% | |
| Jun 2026 | $301.03M | -22.4% | -28.9% | 10.6% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $237.27M | +27.1% | -3.5% | 49.3% |
BLLNBillionToOne, Inc. | Jun 2026 | $192.89M | +34.4% | — | 26.4% |
| Mar 2026 | $112.22M | +35.2% | -2.8% | 9.7% | |
| Jun 2026 | $97.96M | -20.4% | +5.9% | 6.6% | |
| Peer median (excluding BLLN) | $318.67M | +19.4% | -0.0% | 36.6% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.